CD8A and neoplasm: Moreover, Mlecnik et al38 concluded that assessing intratumoral CD8+ T‐cell density in combined tumor regions, the center of the tumor and the invasive margin, provides an indicator of tumor recurrence beyond that predicted by AJCC/UICC‐TNM staging.